Indication
Frontal Fibrosing Alopecia
4 clinical trials
4 products
Clinical trial
A Phase 2a, Randomized, Double-Blind, Vehicle-Controlled, Single Site, Exploratory Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing AlopeciaStatus: Completed, Estimated PCD: 2023-02-13
Product
DelgocitinibClinical trial
Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot StudyStatus: , Estimated PCD: 2024-04-05
Product
TofacitinibClinical trial
Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring AlopeciaStatus: Completed, Estimated PCD: 2021-10-11
Product
Topical GabapentinClinical trial
A Pilot Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)Status: Recruiting, Estimated PCD: 2025-04-30
Product
Baricitinib